Company Filing History:
1 out of 2 
1 out of 2,012 
Years Active: 2025
Title: Lynn Cheatham: Innovating Transplant Medicine
Introduction
Lynn Cheatham, an accomplished inventor based in Durham, NC, has made significant strides in the field of transplant medicine. With a focus on enhancing the effectiveness of organ transplants, he is the holder of a unique patent that addresses critical challenges in immunology and transplantation.
Latest Patents
Lynn Cheatham’s notable patent is titled "Methods of determining the suitability of cultured thymus tissue for implantation into humans and associated methods of use." This invention provides innovative methods and compositions for promoting donor-specific tolerance and immunocompetence in recipients of solid organ transplants. It details processes for implanting allogeneic solid organs alongside tissue-engineered postnatal thymus tissue products. Additionally, it outlines methods for producing and culturing the thymus tissue-derived products suitable for human implantation, thus enhancing the potential success of organ transplants.
Career Highlights
Throughout his career, Lynn Cheatham has contributed his expertise in both academic and corporate environments. He has worked with Enzyvant Therapeutics GmbH, where he helped advance biotechnology innovations, and Duke University, a prestigious research institution renowned for its advancements in medical science and technology.
Collaborations
During his professional journey, Lynn has collaborated with notable individuals in the field, including Mary Louise Markert and Laura P. Hale. These partnerships have been pivotal in driving forward research and development in thymus tissue and transplant methodologies.
Conclusion
Lynn Cheatham exemplifies the spirit of innovation in the transplantation domain. His patent and contributions not only enhance the methodologies surrounding organ transplant procedures but also reflect the collaborative nature of advancements in medical science. As research continues, the implications of his work could significantly benefit countless patients in need of life-saving transplants.